COURSE SUMMARY

Cost: Free

Start Date: 06/05/2021

Expiration Date: 06/05/2021

Target Audience: Primary Care

Format: Live Virtual

Estimated Time To Complete CME Activity: 5.75 hours

Credits:
5.75 AMA PRA Category 1 CreditsTM
5.75 AANP Contact Hours including 2.25 pharmacology hours

Hardware/Software Requirements: Any web browser

Date: Sat, Jun 5th 2021 09:00 am – 06:20 pm EDT

Add To Calendar

Broadcast Live
Start Time 9:00 AM EDT
Broadcast Live,

Join us online from the comfort and safety of your home or office!


In response to the COVID-19 pandemic, NACE will continue to provide our Emerging Challenges and Clinical Updates live, regional events virtually through the end of 2021.

We will recreate the onsite learning experience you are accustomed to in our virtual environment. You will have opportunities to engage with faculty and colleagues online, earn CME/CE credit, and stay up to date on the issues that matter most to you and your patients.

Registration
There is no registration fee for this activity.

Special Accommodations
NACE fully complies with the legal requirements of the Americans with Disabilities Act. Any activity registrant who feels s/he may need accommodations based on the impact of a disability should contact NACE to discuss your specific need.

Program Summary
Please join us online and become an active participant in this one-day learning community of your peers:

Primary care providers face complex challenges everyday in their busy practices. With rapid changes in medicine, staying informed about new developments can be equally challenging. Our goal in this CME activity is to help you hone your skills in the diagnosis and management of patients with varied conditions you are likely encountering in your practice.

We have recruited a faculty of well-known thought leaders and experienced teachers who, as clinicians themselves, understand the challenges you face every day as a primary care provider. Our faculty will be at your disposal to provide evidence-based science, current treatment guidelines, discuss challenging cases, and provide answers for you that can ultimately lead to better health care for your patients. The presentations will include several interactive cases and discussion sessions to keep you actively learning.

Learning Objectives

Effective Management of Pulmonary Arterial Hypertension: Primary Care’s Primary Role

Perspectives on PrEP: Patient Conversations

COVID-19 Update

Learning from the Patient in ADHD: A Standardized Patient Program

Bringing Diabetes into the 21st Century: A Two Part Continuous Glucose Monitoring (CGM) Workshop Part 1: The Broad Utility of CGM in Clinical Practice

Advances in Lipid Management: Evolving Strategies for Risk Reduction, Adherence, and Shared Decision-Making for Patients with Hypercholesterolemia

Agenda*

9:00 – 9:05 AM
Welcome Remarks
Gregg Sherman, MD and Ashlyn Smith, PA-C

9:05 – 10:05
Effective Management of Pulmonary Arterial Hypertension: Primary Care’s Primary Role
Franck Rahaghi, MD, MHS, FCCP 
Moderator: Ashlyn Smith, PA-C

10:05 – 10:20
Break

10:20 – 11:20
Presentation Theater: Shifting Perspectives: How Do You Choose the Next Oral Therapy for T2D?
(CME not offered)

11:20 – 11:30
Break

11:30 – 12:35 PM
Perspectives on PrEP: Patient Conversations
Ellen F. Eaton, MD, MSPH 
Moderator: Gregg Sherman, MD

12:35 – 12:50
Break

12:50 – 1:50
Presentation Theater: When Topicals Aren’t Enough: An Oral Non-Biologic Treatment Option for Plaque Psoriasis 
(CME not offered)

1:50 – 2:00
Break

2:00 – 2:45
COVID-19 Update
Leana S. Wen, MD, MSc 
Moderator: Neil Skolnik, MD

2:45 – 2:55
Break

2:55 – 3:55
Learning from the Patient in ADHD: A Standardized Patient Program
Gregory Mattingly, MD
Moderator: Gregg Sherman, MD

3:55 – 4:05
Break

4:05 – 5:05
Bringing Diabetes into the 21st Century: A Two Part Continuous Glucose Monitoring (CGM) Workshop
Part 1: The Broad Utility of CGM in Clinical Practice
Eden Miller, DO
Moderator: Ashlyn Smith, PA-C

5:05 – 5:15
Break

5:15 – 6:15
Advances in Lipid Management: Evolving Strategies for Risk Reduction, Adherence, and Shared Decision-Making for Patients with Hypercholesterolemia
James A. Underberg, MD, MS, FACPM, FACP 
Moderator: Gregg Sherman, MD

6:15 – 6:20
Closing Remarks
Moderator: Gregg Sherman, MD

* Subject to Change

Faculty

Ellen F. Eaton, MD, MSPH 
Assistant Professor of Medicine 
Division of Infectious Disease
University of Alabama at Birmingham 
Birmingham, AL

Gregory Mattingly, MD
Associate Clinical Professor, Washington University 
President, Midwest Research Group
Board of Directors, American Professional Society for ADHD and Related Disorders 
St. Louis, MO

Eden Miller, DO
Founder, Diabetes and Obesity Care 
Bend, OR

Franck Rahaghi, MD, MHS, FCCP 
Director of Advanced Lung Disease Clinic
Director, Pulmonary Hypertension Clinic 
Chairman, Dept. of Pulmonary and Critical Care 
Cleveland Clinic Florida
Weston, FL

James A. Underberg, MD, MS, FACPM, FACP 
Lipidology & Cardiovascular Disease Prevention 
Diplomate American Board of Clinical Lipidology 
Clinical Assistant Professor of Medicine
NYU Medical School & NYU Center for CV Prevention 
Director, Bellevue Hospital Lipid Clinic
Past-President National Lipid Association 
President American Board of Clinical Lipidology 
New York, NY

Leana S. Wen, MD, MSc
Visiting Professor, Health Policy and Management
Distinguished Fellow, Fitzhugh Mullan Institute for Health Workforce Equity 
George Washington University School of Public Health 
Washington, DC

Moderators

Ashlyn Smith, PA-C 
Endocrinology Associates, P.A.
President, American Society of Endocrine 
Physician Assistants
Adjunct Assistant Professor, Midwestern University 
Glendale, AZ

Gregg Sherman, MD 
Chief Medical Officer
National Association for Continuing Education 
Plantation, FL

Neil Skolnik, MD
Professor of Family and Community Medicine 
Sidney Kimmel Medical College
Thomas Jefferson University 
Associate Director
Family Medicine Residency Program
Abington Jefferson Health 
Philadelphia, PA

Planning Committee

Sandy Bihlmeyer, MEd 
Senior Project Manager
National Association for Continuing Education 
Plantation, FL

Michelle Frisch, MPH
Vice President, Operations
National Association for Continuing Education 
Plantation, FL

Angela Golden, DNP, FNP-C, FAANP 
Family Nurse Practitioner
NP Obesity Treatment Clinic and NP from Home, LLC 
Assistant Professor (Ret), Northern Arizona University
Past President, American Association of Nurse Practitioners 
Munds Park, AZ

Daniela Hiedra 
Activity Director
National Association for Continuing Education 
Plantation, FL

Joshua F. Kilbridge
President and Creative Director 
Kilbridge Associates
San Francisco, CA

Sheila Lucas, CWEP 
Activity Director
National Association for Continuing Education 
Plantation, FL

Gregg Sherman, MD 
Course Director Chief Medical Officer
National Association for Continuing Education 
Plantation, FL

Nicholas Zittell, CHCP
National Association for Continuing Education 
Plantation, FL

 

Provided By
National Association for Continuing Education

NACE AANP Approval
National Association for Continuing Education is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 121222. This activity is approved for 5.75 contact hours (which includes 2.25 hours of pharmacology).

NACE Accreditation Statement
The National Association for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

NACE Credit Designation Statement
The National Association for Continuing Education designates this live activity for a maximum of 5.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Policy on Faculty and Provider Disclosure
Accredited education provided by the National Association for Continuing Education (NACE) must demonstrate balance, independence, objectivity, and scientific rigor. All individuals in a position to influence content of NACE accredited education are required to disclose all financial relationships with ineligible companies within the previous 24 month period, regardless of relevance to the education. All relevant financial relationships and potential conflicts of interest will be mitigated prior to the activity.

NACE defines ineligible companies as those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

NACE Commercial Support

This educational activity is supported in part by an educational grant from Esperion Therapeutics, Inc.; an educational grant from Abbott Diabetes Care Inc.; an educational grant from Actelion Pharmaceuticals US, Inc., a Janssen Pharmaceutical Company of Johnson & Johnson; an educational grant provided by Takeda, Inc.; and an educational grant from Gilead Sciences, Inc.

Privacy Policy

Terms & Conditions

_1624311801527